Cargando…
Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline
1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) is neurotoxic when administered to the brain and alters motor behaviour following intraperitoneal administration. We have assessed the long-term effects of oral TaClo administration on nocturnal motor behaviour in rats. Two groups of rats rece...
Autores principales: | Sontag, Thomas A., Lange, Klaus W., Heim, Christine, Kolasiewicz, Waclav, Tucha, Oliver, Sontag, Karl-Heinz |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847152/ https://www.ncbi.nlm.nih.gov/pubmed/19609633 http://dx.doi.org/10.1007/s00702-009-0261-6 |
Ejemplares similares
-
1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) Induces the Apoptosis of Dopaminergic Neurons via Oxidative Stress and Neuroinflammation
por: Yang, Yihang, et al.
Publicado: (2019) -
Basic studies on epigenetic carcinogenesis of low-dose exposure to 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) in vitro
por: Wang, Renjie, et al.
Publicado: (2017) -
Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension
por: Dreissen, Yasmine Emma Maria, et al.
Publicado: (2019) -
Factors associated with augmentation in patients with restless legs syndrome
por: Heim, Beatrice, et al.
Publicado: (2021) -
Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency
por: Mochel, Fanny, et al.
Publicado: (2016)